Madrigal Pharmaceuticals (MDGL) earnings

Earnings (net income) · fiscal 2025
-$288.28M

Madrigal Pharmaceuticals (MDGL) reported net income of -$288.28M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$465.89M. Figures as of 18 Nov 2026, 01:22 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$288.28M
Highest on record
-$26.39Mfiscal 2016
Lowest on record
-$465.89Mfiscal 2024
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Madrigal Pharmaceuticals earnings, in more detail

Across the 10 fiscal years on record (2016–2025), the highest was -$26.39M in fiscal 2016 and the lowest -$465.89M in fiscal 2024.

History · 10 fiscal years

Earnings (net income) by fiscal year

Madrigal Pharmaceuticals earnings, year by year

Madrigal Pharmaceuticals (MDGL) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$288.28M—
2024-$465.89M—
2023-$373.63M—
2022-$295.35M—
2021-$241.85M—
2020-$202.24M—
2019-$83.95M—
2018-$32.81M—
2017-$31.15M—
2016-$26.39M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Madrigal Pharmaceuticals and comparable companies
CompanyEarnings (net income)Fiscal year
Qiagen QGEN$424.88M2025
Insulet PODD$247.10M2025
Bruker BRKR-$8.60M2025
Globus Medical GMED$537.87M2025
Madrigal Pharmaceuticals MDGL-$288.28M2025
Henry Schein HSIC$398.00M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MDGL

Madrigal Pharmaceuticals, figure by figure

Madrigal Pharmaceuticals (MDGL) overview: price, valuation and scorecardAll health care companies by market value

Madrigal Pharmaceuticals earnings: questions and answers

What is Madrigal Pharmaceuticals's net income?

Madrigal Pharmaceuticals (MDGL) reported net income of -$288.28M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$465.89M.

What are the highest and lowest net income figures on record for Madrigal Pharmaceuticals?

Across the 10 fiscal years on record (2016–2025), the highest was -$26.39M in fiscal 2016 and the lowest -$465.89M in fiscal 2024.

How is Madrigal Pharmaceuticals's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Madrigal Pharmaceuticals (MDGL) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/MDGL/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.